LineaDNA for Personalized Medicine
Patient-Specific Therapies
Research/PlatformActive Potential
Key Facts
About LineaRx
LineaRx, a subsidiary of Applied DNA Sciences, Inc. (APDN), was founded in 2018 to commercialize over two decades of enzymatic DNA production expertise. Its mission is to overcome the critical bottleneck of plasmid DNA manufacturing by providing a faster, purer, and more scalable DNA production platform. The company's strategy is to function as a technology and product supplier, enabling partners across the biopharmaceutical industry to advance their therapeutic pipelines from research through commercial manufacturing.
View full company profile